Hextar Healthcare Berhad reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was MYR 40.07 million compared to MYR 63.2 million a year ago. Net loss was MYR 56.38 million compared to net income of MYR 9.29 million a year ago. Basic loss per share from continuing operations was MYR 0.063 compared to basic earnings per share from continuing operations of MYR 0.0107 a year ago.
For the full year, sales was MYR 174.97 million compared to MYR 509.95 million a year ago. Net loss was MYR 56.14 million compared to net income of MYR 185.74 million a year ago. Basic loss per share from continuing operations was MYR 0.0627 compared to basic earnings per share from continuing operations of MYR 0.2179 a year ago.